Â鶹ŮÓÅ

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Medicaid Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • Â鶹ŮÓÅ Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Emergency Room Boarding
  • Device Coverage by Medicare
  • Planned Parenthood Funding
  • Covid/Flu Combo Shot
  • RFK Jr. vs. Congress

TRENDING TOPICS:

  • Emergency Room Boarding
  • Device Coverage by Medicare
  • Planned Parenthood Funding
  • Covid/Flu Combo Shot
  • RFK Jr. vs. Congress

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Friday, Apr 10 2015

Full Issue

Heart Disease-Testing Labs To Pay $48.5M To Settle Claims

Health Diagnostics Laboratory and Singulex have agreed to pay at least $47 million and $1.5 million respectively to settle Justice Department allegations they paid doctors kickbacks and conducted unnecessary testing. Neither admitted liability.

U.S. cardiovascular disease testing laboratories Health Diagnostics Laboratory Inc (HDL) and Singulex Inc have agreed to pay $48.5 million to settle claims they paid kickbacks and conducted unnecessary testing, the U.S. Department of Justice said on Thursday. Both U.S. companies were accused of violating the False Claims Act by paying physicians in exchange for patient referrals and billing federal healthcare programs, including Medicare, for medically unnecessary testing, according to court documents. (4/9)

Federal authorities are cracking down on cardiac biomarker laboratories that they allege paid doctors kickbacks to provide patients’ blood samples for testing. Health Diagnostic Laboratory Inc. and Singulex Inc. agreed to pay at least $47 million and $1.5 million, respectively, to settle civil allegations filed by the Justice Department that they paid doctors for patient blood and billed Medicare for medically unnecessary testing. (Carreyrou, 4/19)

Meanwhile, Walgreens will close about 200 stores as it combines with Alliance Boots -

Walgreens will shutter about 200 U.S. stores as part of an expanded cost reduction push, but the nation’s largest drugstore chain has no plans to shrink in the wake of its combination with European health and beauty retailer Alliance Boots. The Deerfield, Illinois, company expects to open roughly the same number of stores and will consider more mergers and acquisitions, even as it continues to digest a nearly $16 billion deal that finalized its combination with Alliance Boots, which runs the United Kingdom’s largest pharmacy chain. (Murphy, 4/9)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, April 24
  • Thursday, April 23
  • Wednesday, April 22
  • Tuesday, April 21
  • Monday, April 20
  • Friday, April 17
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 Â鶹ŮÓÅ